| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.011 | 1 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.011 | 1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |